MMP25 and neoplasm: Previous studies reported that MMP25-AS1/hsa-miR-10a-5p/SERPINE1 axis is a new prognostic biomarker related to the infiltration of immune cells in KIRC (44), tumor antigen, and immune subtype, guiding the development of mRNA vaccine for clearing renal cell carcinoma (45).